Skip to content
Open access

Signs of antidepressant-like effects of temozolomide as measured in the forced-swim test in adult rats.

Sep 2026 · Pharmacological Reports · 1 citation · 45 references
Medicine

TL;DR

Temozolomide induced signs of antidepressant-like responses as measured in the forced-swim test in a treatment-duration manner and decreased NeuroD and hippocampal FADD, a neuroplastic marker previously associated with the acute and repeated actions of most antidepressants.

Abstract

Background

Temozolomide is the gold standard chemotherapeutic agent for glioblastoma multiforme. Yet its pharmacological use has been linked to the emergence of depressive- and/or anxiety-like behaviors, probably through the inhibition of hippocampal neurogenesis. Since prior studies reporting these negative effects were based on prolonged treatment paradigms (from 2 weeks to up to 6 months), and given the lack of studies including females, our approach aimed at further characterizing the behavioral effects induced by temozolomide (25 mg/kg, 1 or 2 cycles, 5 days/cycle) in a adult rats of both sexes.

Methods

Rats were scored across time through specific behavioral tests that capture diverse manifestations of affective-like responses (forced-swim, open field, novelty-suppressed feeding, sucrose preference) or cognitive performance (Barnes maze). At the neurochemical level, we ascertained the effects of 2 cycles of temozolomide on an early stage of hippocampal neurogenesis (neural progenitors, NeuroD) and other potential neuroplasticity targets (mature BDNF, FADD).

Results

Temozolomide induced signs of antidepressant-like responses as measured in the forced-swim test in a treatment-duration manner. It also decreased NeuroD and hippocampal FADD, a neuroplastic marker previously associated with the acute and repeated actions of most antidepressants. These results suggested that other mechanisms of action might be associated with temozolomide's behavioral effects besides hippocampal neurogenesis, such as the correlative one described through the neuroplastic molecule FADD.

Conclusions

In conjunction with the prior data, our results suggested cycle- and/or length-dependent treatment effects in terms of temozolomide's antidepressant- vs. depressant-like profile, while proposing a novel biomarker related to treatment response.

Read PDF

Similar papers

Open access Nov 2026

Studying the pharmacological interaction of temozolomide chemotherapy with different antidepressant treatments in a rat glioblastoma model.

PURPOSE The present study evaluated the pharmacological interaction of temozolomide (TMZ) chemotherapy with 3 potential antidepressant treatments (cannabidiol, CBD; fluoxetine, FLX; metformin, MET) in a rat glioblastoma model with the objective of finding drug combinations to better treat the depressive symptoms observ...

Laura Gálvez-Melero, Julia Bihorac, M. Hadamitzky et al. · 0 citations
Open access Sep 2026

Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats.

Evaluated behavioral and neurochemical effects of ayahuasca treatment in Wistar rats subjected to an animal model of depression induced by maternal deprivation showed significant therapeutic potential, highlighting the need for translational research of new pharmacological approaches for MDD.

Guilherme Lodetti, Henrique Redivo, Amanda Gomes Teixeira et al. · 0 citations
Open access Sep 2026

Perampanel Attenuates Cognitive and Behavioral Deficits and Modulates Hippocampal Tachykinin Expression in Experimental Temporal Lobe Epilepsy

Background: Epilepsy is one of the most prevalent neurological disorders, often presenting alongside many comorbidities. The present study aimed to evaluate the impact of the antiepileptic drug perampanel (PRM) on cognitive function, depressive-like behavior and the expression of substance P (SP) and neurokinin B (NKB)...

M. Shishmanova-Doseva, D. Barbutska, Y. Koeva · 0 citations
Open access 2026

Antidepressant- and Anxiolytic-like Effects of Nicotinamide in a Chronic Unpredictable Mild Stress Mouse Model

Depression and anxiety are common stress-related neuropsychiatric disorders associated with impaired neuroplasticity, oxidative stress, neuroinflammation, and altered cellular energy metabolism. Nicotinamide, a precursor of nicotinamide adenine dinucleotide (NAD⁺), has emerged as a potential neuroprotective agent, alth...

U. A. Muhammad, Y. Yusha'u, Benjamin G. Otuya · 0 citations
Oct 2026

Evaluation of Anti-Depressant, Anxiolytic, and Cognitive Improvement Effects of Nanocurcumin Using Social Isolation Model in Male Mice: Behavioral and Histopathological Evaluation.

Major Depressive Disorder (MDD) is a heterogeneous mental illness that affects about 10% of people worldwide. Curcumin (Cur) is suggested as a treatment or adjunct treatment of MDD by multiple mechanisms of action. Its effectiveness is limited due to low solubility, poor bioavailability, and rapid metabolization. Diffe...

Namra Irshad, H. Ghafari, Saba Esmaeili et al. · 0 citations
Open access Oct 2026

L-Theanine Ameliorates Chronic Unpredictable Mild Stress-Induced Depressive Behavior Through Differential Modulation of Hippocampus and Prefrontal Cortex

LT exerted an antidepressant-like effect in mice exposed to CUMS by increasing serotonin, glutamate, and nitrite in the PFC and decreasing glutamate in the hippocampus as compared to its respective control.

A. Balyan, Kaushik Madan, Vaibhav Walia · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.